Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological Standardization of Cupressus Arizonica Allergen Extract
NCT02512653Phase 2Completed
- Sponsor
- LETI Pharma
- Start
- Nov 2015
- Primary completion
- Dec 2015
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of cupressus arizonica pollen in Tree Pollen Allergy (TPA), sponsored by LETI Pharma. Started Nov 2015; status: completed.
02
Drugs
cupressus arizonica pollen
03
Conditions
Tree Pollen Allergy (TPA)
Beyond the preview
Go deeper on NCT02512653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02512653.